Enwei Pharmaceutical Co., Ltd. (SHE:301331)

Enwei Pharmaceutical Revenue

Enwei Pharmaceutical had revenue of 196.50M CNY in the quarter ending March 31, 2025, with 7.10% growth. This brings the company's revenue in the last twelve months to 825.15M, up 7.46% year-over-year. In the year 2024, Enwei Pharmaceutical had annual revenue of 812.13M with 3.43% growth.

• Revenue (ttm): 825.15M
• Revenue Growth: +7.46%
• P/S Ratio: 4.48
• Revenue / Employee: 533.04K
• Employees: 1,548
• Market Cap: 3.69B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	812.13M	26.94M	3.43%
Dec 31, 2023	785.19M	93.62M	13.54%
Jan 1, 2023	691.57M	11.88M	1.75%
Jan 1, 2022	679.70M	45.54M	7.18%
Dec 31, 2020	634.16M	13.49M	2.17%